Eurobike Award & Interbike Innovation Award Winner
CAPE TOWN, South Africa, August 31, 2017 – Leatt Corporation (OTCQB: LEAT), a developer and marketer of protective equipment and ancillary products for many forms of sports, especially extreme high-velocity sports, announced today that the all-new Leatt DBX 3.5 neck brace has won prestigious awards at the annual Eurobike and Interbike international bicycle industry trade events.
The Interbike International Bicycle Exposition is the largest bicycle industry trade event in North America and their awards are aimed at recognizing excellence and innovation in product, retail and advocacy.
Eurobike is the world’s leading trade fair where international bike industry exhibitors present their products and services. The prestigious Eurobike Award honors innovative products and is a highlight of the annual exposition. The Eurobike Award Jury commented regarding the Leatt DBX 3.5 neck brace, “This very lightweight design now places a key item of safety equipment within an attractive price range.”
Leatt CEO, Sean Macdonald remarked, “Years of research, development and testing has continued to pay off as another of our technologically innovative products has won two of the cycling world’s most coveted and prestigious awards. Our new neck brace, featuring a unique combination of in-molded EPS construction with a polyamide core, similar to what is found in high-performance bicycle helmets, has allowed us to reduce both weight and cost for the benefit of thrill-seeking gravity riders worldwide.”
Dr. Christopher Leatt, Chairman of the Board added, “We are very proud to have won these awards and to be recognized by our industry. We view this as a tribute to our innovation and engineering capabilities and remain committed to protecting both the professional and amateur athletes across the world.
“While Leatt’s 5.5 and 6.5 neck brace models do offer a more custom fit than the new 3.5 brace, the semi-rigid chassis still has enough adjustment to fit most riders’ body shapes. As with all Leatt neck brace models, the DBX 3.5 is CE certified as Personal Protective Equipment and has been lab-tested and proven to help reduce neck forces, lowering the chances of a serious neck injury.”
The Leatt DBX 3.5 Neck Brace is the lightest neck brace in the Leatt range, approximately 30% lighter than the existing 5.5 models. It is also the most cost-effective Leatt neck brace ever produced and will be available in store from the first quarter of 2018.
The European launch of the 2018 gear line and the new award-winning Leatt DBX 3.5 neck brace will be on display at the Eurobike International Bicycle Exhibition in Friedrichshafen, Germany, August 30 – September 2, 2017 (Booth B4-204). The North American launch will be at the Interbike International Bicycle Exposition at the Mandalay Bay Convention Center in Las Vegas, September 20 – 22, 2017 (Booth 24243).
More detailed product information can be found on recently relaunched www.leatt.com.
About Leatt Corporation:
Leatt Corporation develops personal protective equipment and ancillary products for all forms of sports, especially extreme motor sports. The Leatt-Brace® is an award-winning neck brace system considered the gold standard for neck protection for anyone wearing a crash helmet as a form of protection. It was designed for participants in extreme sports or riding motorcycles, bicycles, mountain bicycles, all-terrain vehicles, snowmobiles and other vehicles. For more information, visit: www.leatt-corp.com.
This press release may contain forward-looking statements regarding Leatt Corporation (the “Company”) within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are “forward-looking statements”, including statements regarding: the significance of the two awards to the Company’s results of operation; the financial outlook of the Company; the general ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “seeks,” “should,” “could,” “intends,” or “projects” or similar expressions, and involve known and unknown risks and uncertainties. These statements are based upon the Company’s current expectations and speak only as of the date hereof. Any indication of the merits of a claim does not necessarily mean the claim will prevail at trial or otherwise. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company’s actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company’s common stock as a “penny stock” and those listed in other reports posted on The OTC Markets Group, Inc.
Chief Executive Officer
+ (27) 21 557 7257
Michael Mason (Investors)
Len Hall (Media)